Thomas Jefferson University researchers argue that they have developed a new imaging test able to detect prostate cancer better than any other radiographic, blood, or biopsy test in use today. The study detected 80 percent of cancers seen pathologically, providing deep insight into the accuracy of prostate cancer imaging. The research team also investigated the PET imaging agent in human breast cancer. You can read more here.
Last Updated on May 7, 2020 by Aimed Alliance
